cardiovascular benefits of glp 1 agonists GLP-1 Receptor for the Reduction Atherosclerotic Risk in Patients With Type 2 Diabetes The Benefits of GLP-1 Therapy:

[DOI] [PubMed] [Google Scholar] 41.Rzepka P.V., Kaffenberger J.A

evaluated serum extracellular vesicles as part of a secondary analysis [90], expanding on the positive primary clinical trial outcomes [87]

For patients with higher HbA1c levels, no initial insulin dose reduction is typically needed [41,42,43]

Patients with these conditions who also have elevated inflammatory markers may experience additional anti-inflammatory benefits, but use solely for inflammation outside established indications is not recommended

Hikma Pharmaceuticals Hikma is working on generic versions and biosimilars of GLP-1 drugs to improve accessibility and affordability in developing markets

2014 doi: 10.1097/DAD.0000000000000243